A Novel Histone Deacetylase Inhibitor, CKD5, Has Potent Anti-Cancer Effects in Glioblastoma

Oncotarget- United States

doi 10.18632/oncotarget.13265

Full Text

Abstract

Available in

Categories

Date

November 10, 2016

Authors

Publisher

Impact Journals, LLC

Related search

Preclinical Anti-Arthritic Study and Pharmacokinetic Properties of a Potent Histone Deacetylase Inhibitor MPT0G009

Cell Death and Disease

Molecular Neuroscience

Cancer Research

English

Santacruzamate A, a Potent and Selective Histone Deacetylase Inhibitor From the Panamanian Marine Cyanobacterium cf.Symplocasp.

Journal of Natural Products

Organic Chemistry

Molecular Medicine

Pharmaceutical Science

Analytical Chemistry

Alternative Medicine

English

A Chimeric SERM-Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy

Organic Chemistry

Molecular Medicine

English

Activity of PXD101, a Histone Deacetylase Inhibitor, in Preclinical Ovarian Cancer Studies

Molecular Cancer Therapeutics

Cancer Research

English

Givinostat, a Type II Histone Deacetylase Inhibitor, Induces Potent Caspase-Dependent Apoptosis in Human Lymphoblastic Leukemia

Genes and Cancer

Cancer Research

English

Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells

Antioxidants and Redox Signaling

Molecular Biology

Clinical Biochemistry

English

Selective Inhibition of IL-Gene Expression by 2Trichostatin A, a Potent Inhibitor of Mammalian Histone Deacetylase.

Journal of Antibiotics

English

Discovery of N-(2-Aminophenyl)-4-(Bis(2-Chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor

Frontiers in Pharmacology

English

Preclinical Validation of AR42, a Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas

Otorhinolaryngology

English